New hope for stroke patients: drug may work even after 4.5 hours

NCT ID NCT06994975

Recruiting now Disease control Sponsor: Huashan Hospital Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 24 times

Summary

This study tests a clot-busting drug called tenecteplase in Chinese stroke patients who arrive at the hospital more than 4.5 hours after symptoms start. About 890 participants will receive either the drug or standard care to see if it helps them recover without disability. The goal is to find a safe and effective treatment for patients who currently have limited options.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Huashan Hospital
RECRUITING

Shanghai, Shanghai Municipality, 200040, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Huashan Hospital, Fudan University
NOT_YET_RECRUITING

Shanghai, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ACUTE ISCHEMIC STROKE